Pharmacia and Paladin Enter Into Distribution Agreement for Certain Endocrinology and Women's Health Brands
21-Jan-2002
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Novartis and Alnylam Create Major Alliance to Discover RNAi Therapeutics
Go to page
ThromboGenics and BioInvent Awarded Euro 2 Million EU Grant for ANGIOSTOP Anti-Angiogenesis Programme
Go to page
Cancer genes hijack enhancers
Go to page
DOYMA GmbH & CO - Oyten, Germany
Go to page
AstraZeneca Pharmaceuticals LP Selects Ariba Enterprise Sourcing
Go to page
LEONHARD WEISS GmbH & Co. KG - Satteldorf, Germany
Go to page
Radiation_therapy
Go to page
Synvolux Therapeutics B.V. - Groningen, Netherlands
Go to page
FDA has approved Zealand Pharma's Investigative New Drug application for ZP1846 to be administered in humans - ZP1846 developed for the prevention and treatment of severe diarrhoea induced by chemotherapy
Go to page
Primary endpoint reached in Active Biotech's TASQ Phase II clinical trial in prostate cancer patients
Go to page
CryoLife to Receive $2.25 Million to Settle Dispute
Go to page